The APIs listed below are the main Anti-Asthma / COPD ingredients that are presently available from LGM Pharma:
- Aclidinium Bromide
- Bepotastine Besylate
- Budesonide
- Ciclesonide
- Clemastine Fumarate
- Fluticasone Propionate
- Formoterol Fumarate
- Indacaterol Maleate
- Levalbuterol Hydrochloride
- Mometasone Furoate
- Montelukast Sodium
- Nedocromil Sodium
- Pranlukast
- Salmeterol Xinafoate
- Tiotropium Bromide
- Vilanterol Trifenatate
We constantly aim to provide top technical support and full regulatory documentation (TDP / CTD / E-DMF / CEP / US-DMF etc…) even for the most recently approved APIs, originating from EU-GMP certified and US-FDA approved production facilities. Many of the above APIs are manufactured via non-infringing routes of synthesis and would be suitable for Paragraph IV challenges / early launch in regulated markets.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1).
Any patent infringement and resulting liability is solely at buyer risk.
